Apeiron Therapeutics
PrivateLast Round
Series A
Mar 29, 2022
Total Funding Raised
$44.5M
Company Overview
Apeiron Therapeutics is a biotechnology company that develops biomarker-driven cancer therapeutics using a structure-based, AI-driven drug design platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apeiron Therapeutics Comparables
Compare Apeiron Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Recursion Pharmaceuticals | 81% | |
| Tango Therapeutics | 80% | |
| Bristol Myers Squibb | 78% | |
Apeiron Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 29, 2022 | ||||
| Seed | Jun 11, 2019 |
Apeiron Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viva BioInnovator | Series A |
| GT Healthcare Capital Partners | Seed |
| Panacea Venture Healthcare | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors grew 80% MoM, reaching 1.2K.
- May 1, 2025
Monthly visitors grew 298% MoM, from 377 to 1.5K.
Apeiron Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apeiron Therapeutics's valuation, stock price, and market status.